Description
Risk Factors for Psychosis: Paradigms, Mechanisms, and Prevention combines the related, but disparate research endeavors into a single text that considers all risk factors for psychosis, including biological, psychological and environmental factors. The book also introduces the ethics and current treatment evidence that attempts to ameliorate risk or reduce the number of individuals with risk factors developing a psychotic disorder. Finally, the book highlights new research paradigms that will further enhance the field in the future.Psychotic disorders affect more than 50 million people worldwide, creating a devastating effect on lives and causing major financial and emotional impact on families and on society as a whole. The search for risk factors for psychosis has developed rapidly over the past decades, invigorated by changes in the thinking about the malleability and treatability of psychotic disorders. The paradigms for investigating psychosis risk have developed, often in parallel, but there has been no book to date that has summarized and synthesized the current approaches.- Integrates research from biological, psychological and environmental factors into a single resource- Offers insight into at-risk paradigms, biomarkers, and the current state of research on treatment option for psychosis- Presents a holistic and dynamic look at risk syndromes and how they can be measured through neuroimaging, neuropsychology and other methods
Table of Contents
1. Historical perspectives on psychosis riskCRISTINA MEI AND PATRICK D. MCGORRY2. Principles of risk, screening, and prevention in psychiatryEMMA SONESON, JESUS PEREZ, AND PETER B. JONESI - Risk paradigms3. At-risk mental statesALISON R. YUNG4. Subjective disturbances in emerging psychosis: basic symptoms and self-disturbancesFRAUKE SCHULTZE-LUTTER, CHANTAL MICHEL, RAHEL FL €UCKIGER, AND ANASTASIA THEODORIDOU5. Schizotypy, schizotypal personality, and psychosis riskNEUS BARRANTES-VIDAL, ANNA RACIOPPI, AND THOMAS R. KWAPIL6. Familial high risk and high-risk studiesLIANA ROMANIUK, STELLA W.Y. CHAN, ALIX MACDONALD, JESSIKA E. SUSSMANN, ANDREW M. MCINTOSH, HEATHER C. WHALLEY, AND STEPHEN M. LAWRIE7. Psychotic-like experiences in the general populationCOLM HEALY AND MARY CANNON8. 22q11.2 deletion syndrome: a neurodevelopmental model of psychosisCORRADO SANDINI, STEPHAN ELIEZ, MAUDE SCHNEIDER, AND MARCO ARMANDOII - Specific areas and risk9. Neuroimaging studies in people at clinical high risk for psychosisGEORGE GIFFORD, ROB MCCUTCHEON, AND PHILIP MCGUIRE10. Genetic studies of psychosisHANNAH J. JONES, STANLEY ZAMMIT, AND JAMES T.R. WALTERS11. Immune processes and risk of psychosisADAM AL-DIWANI AND THOMAS ARTHUR NICHOLLS POLLAK12. Neurochemical models of psychosis risk and onsetDOMINIC OLIVER, GEMMA MODINOS, AND PHILIP MCGUIRE13. Clinical risk factors for psychosisASWIN RATHEESH, JESSICA A. HARTMANN, AND BARNABY NELSON14. Cognitive risk factors for psychosisKELLY ALLOTT AND ASHLEIGH LIN15. Society and risk of psychosisCRAIG MORGAN, TESSA ROBERTS, BRIAN O. DONOGHUE, AND ANDREW THOMPSON16. Is there sufficient evidence that cannabis use is a risk factor for psychosis?MARCO COLIZZI AND SAGNIK BHATTACHARYYAIII - Interventions17. The ethics of identifying and treating psychosis riskPAOLO CORSICO AND ILINA SINGHJEAN ADDINGTON, DANIJELA PISKULIC, DANIEL J. DEVOE, OLGA SANTESTEBAN-ECHARRI, AND JACQUELINE STOWKOWY19. Pharmacological intervention for people at risk of psychotic disorderE. BURKHARDT, K. LEOPOLD AND A. BECHDOLF20. International services for assessing and treating psychosis riskCHRISTY L.M. HUI, W.C. CHANG, SHERRY K.W. CHAN, EDWIN H.M. LEE, Y.N. SUEN, AND ERIC Y.H. CHEN21. New paradigms to study psychosis risk: clinical staging, pluripotency, and dynamic predictionRACHAEL SPOONER, JESSICA A. HARTMANN, PATRICK D. MCGORRY, AND BARNABY NELSON22. Future directions in risk researchNIKOLAI ALBERT, LOUISE BIRKEDAL GLENTHØJ, AND MERETE NORDENTOFT
